ELMD (smartvest.com) Short-Term Debt to Capital

High gross profits from the production of therapeutic vests are offset by the costs of an extensive sales representative network, which stabilizes the operating leverage for Electromed, Inc. (ELMD). Revenue is based on the sale of lung therapy systems, where SmartVest devices have become the key driver. The price trajectory of the ELMD asset, where the indicator stands at 0.00, complements business data regarding the provision of care for patients with COPD and cystic fibrosis through medical centers and insurers.

Electromed, Inc. is developing a patent-protected niche in specialized medical equipment with a closed distribution channel. This indicator measures the share of liabilities maturing within one year relative to equity, reflecting current financial stability. The investor monitors the risk of cash flow gaps during sharp spikes in borrowing or the underutilization of leverage to increase profitability. Analyzing the ratio of short-term debt to equity allows for an assessment of the business model's reliability given its dependence on insurance payments.